According to WiseGuy Reports, the Intravenous Packaging Market was valued at USD 7.34 billion in 2024 and reached USD 7.73 billion in 2025. The market is projected to grow to USD 12.8 billion by 2035, registering a CAGR of 5.2% during the 2026–2035 forecast period. Increasing healthcare expenditure, rising demand for sterile packaging, the growing prevalence of chronic diseases, advances in packaging technologies, and stricter regulatory requirements are supporting market development. Key companies profiled include Baxter International, McKesson Corporation, Medline Industries, Nipro Corporation, Fresenius Kabi, Terumo Corporation, Cardinal Health, B. Braun Melsungen, and Smiths Medical.

Market Overview

Intravenous packaging plays a critical role in the delivery and storage of products administered directly into the bloodstream. Packaging systems must provide appropriate protection, maintain product integrity, and support safe handling across healthcare environments.

The market encompasses IV bags, IV bottles, IV sets, and IV cannulas, with plastic, glass, and rubber serving as key material categories. Different packaging configurations are selected according to the characteristics of the medication or fluid and the requirements of healthcare providers.

Applications span chemotherapy, fluid replacement, nutritional support, and medication administration. Hospitals remain major end users, while ambulatory surgical centers and home healthcare services are becoming increasingly important as healthcare delivery models evolve.

Market Size Reached in 2025

The market reached USD 7.73 billion in 2025, increasing from USD 7.34 billion in 2024. Growth reflects continued healthcare utilization and the requirement for reliable packaging systems across treatment settings.

Hospitals account for substantial demand because intravenous therapy is routinely used across multiple departments and treatment programs. The increasing number of medical procedures and hospital-based therapies supports consumption of IV packaging products.

Ambulatory surgical centers provide another source of demand. As selected procedures move toward outpatient settings, the need for appropriate IV delivery and packaging systems can expand beyond conventional hospital environments.

Expected Market Size by 2035

The market is forecast to reach USD 12.8 billion by 2035. Expansion is expected to be supported by increasing healthcare expenditure, chronic disease management, home-based treatment, and continued development of sterile packaging technologies.

Home healthcare represents an important growth opportunity. Improvements in healthcare delivery and patient monitoring are allowing certain therapies to be administered outside traditional hospital settings, increasing the importance of convenient and dependable IV systems.

Emerging healthcare markets can also contribute to long-term expansion as hospitals, clinics, and treatment infrastructure improve.

Market CAGR

The market is expected to register a CAGR of 5.2% from 2026 to 2035. The growth rate reflects increasing demand for intravenous treatments alongside improvements in packaging materials and manufacturing processes.

Technological advancements are helping manufacturers develop packaging systems with improved functionality and compatibility. Manufacturing precision and quality-control processes are also important because IV packaging must meet stringent performance requirements.

Key Growth Drivers

Rising healthcare expenditure is one of the primary factors supporting the industry. Investments in hospitals, treatment facilities, and medical services can increase demand for intravenous delivery products.

The growing prevalence of chronic diseases is another significant driver. Long-term treatment requirements can increase the use of intravenous medications, fluids, and nutritional therapies.

Sterility is central to IV packaging. Healthcare providers require packaging solutions capable of supporting product integrity throughout manufacturing, storage, transportation, and administration.

Regulatory compliance is also influencing product development. Manufacturers must maintain rigorous quality and safety standards, encouraging continued investment in testing, materials, production processes, and packaging technologies.

Emerging Market Trends

Flexible plastic packaging is gaining attention in applications where lightweight construction and ease of handling are important. Plastic formats can also provide manufacturers with opportunities to develop specialized packaging configurations.

Home healthcare is emerging as a significant trend. As healthcare systems explore treatment models that reduce unnecessary hospital stays, packaging suppliers may benefit from increased demand for products suited to decentralized care.

Manufacturers are also focusing on material innovation. Improvements in barrier properties, compatibility, durability, and packaging performance can support safer and more efficient intravenous product delivery.

Automation and advanced manufacturing technologies are contributing to production consistency. Automated processes can improve efficiency and help manufacturers meet stringent quality requirements.

Competitive Landscape

The competitive landscape includes global healthcare companies, medical device manufacturers, pharmaceutical suppliers, and specialized packaging businesses. Companies compete through product reliability, material technology, manufacturing capabilities, regulatory compliance, distribution networks, and innovation.

Baxter International, McKesson Corporation, Amgen Inc., Medline Industries, Draegerwerk AG, Vygon SA, C. R. Bard Inc., Nipro Corporation, Sutures Medical, Fresenius Kabi, Terumo Corporation, Cardinal Health, Eagle Pharmaceuticals, Hospira, B. Braun Melsungen, and Smiths Medical are among the companies profiled.

Market participants are investing in sterile packaging, advanced materials, manufacturing technologies, and solutions suited to evolving healthcare delivery models. With the market expected to reach USD 12.8 billion by 2035, companies that can combine product safety, regulatory performance, and manufacturing efficiency are positioned to capture emerging opportunities.